Atlas Trials

Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects

Clinical trial NCT00043953 · COMPLETED

Trial details

NCT number
NCT00043953
Sponsor
Abbott
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV Infections
Start date
2002-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.